Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

The Rise and Fall of the Age of Psychopharmacology, Paperback / softback Book

The Rise and Fall of the Age of Psychopharmacology Paperback / softback

Paperback / softback

Description

The Age of Psychopharmacology began with a brilliant rise in the 1950s, when for the first time science entered the study of drugs that affect the brain and mind.

But, esteemed historian Edward Shorter argues that there has been a recent fall, as the field has seen its drug offerings impoverished and its diagnoses distorted by the "Diagnostic and Statistical Manual of Mental Disorders." The new drugs, such as Prozac, have been less effective than the old.

The new diagnoses, such as "major depression," have strayed increasingly from the real disorders of most patients.

Behind this disaster has been the invasion of the field by the pharmaceutical industry.

This invasion has paid off commercially but not scientifically: There have been no new classes of psychiatry drugs in the last thirty years.

Given that psychiatry's diagnoses and therapeutics have largely failed, the field has greatly declined from earlier days.

Based on extensive research discovered in litigation, Shorter provides a historical perspective of change and decline over time, concluding that the story of the psychopharmacology is a story of a public health disaster.

Information

£37.99

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information